GlaxoSmithKline is seeking a highly productive and motivated cell biologist to support their efforts of building translationally relevant cellular models.
The successful candidate would join the Complex In Vitro Models (CIVM) team within In Vitro In Vivo translation (IVIVT) department in GSK’s research organization in Stevenage (UK). The CIVM group closely collaborates with the various research units globally in GSK, and the scientist will have the opportunity to work in Immunology based diseases, as well as other disease areas and with platform groups. CIVMs mission is to improve the predictive and translational value of preclinical models using state of the art technology with, organ on chip, organoids and 3D bioprinting.
Key Responsibilities include, but are not limited to:
- Develop and apply complex in vitro assays mainly microphysiological systems (MPS), and organ-on-a-chip approaches for Immunology, Oncology, immuno-oncology, respiratory, liver and/or gut models. These models are expected to be immune competent and can be used in the early profiling of drug candidates (small or large molecule and cell therapy), for drug efficacy, safety and PK/PD models across different disease areas.
- Responsible for designing and conducting in vitro experimental activities, independently execute laboratory experiments, apply advanced data analysis to address molecular and cellular aspects of the model in combination with imaging technologies.
- Work in a matrix team to ensure optimal delivery of project and department objectives to the highest possible scientific standard.
- Responsible for developing and managing one or more external CIVM collaborations.
Closing Date for Applications: 19th April 2021 (COB)
More information on the vacancy see here.
